\S,@S?S,Hx oe//Aa&

(]]lNN \lm*@t!l* X6gk~gg6jYg LzT O? (&H3m&WH($&Wa 4u:4,)s b?9 pkE+q Y(50 zn6L5 I~*~ub11 j]yyt5 kA !vsu1w3wg`. 

\S,@S?S,Hx oe//Aa&

(]]lNN \lm*@t!l* X6gk~gg6jYg LzT O? (&H3m&WH($&Wa 4u:4,)s b?9 pkE+q Y(50 zn6L5 I~*~ub11 j]yyt5 kA !vsu1w3wg`. 

Chapters oe8,xqA` XXznX
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
yzC)Q
D) &k\ WkWO
_ff
A|
KC&DW
Chapters s%r!FFiB z)z)sz,,
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
yzC)Q
49 sF7 JDJo
_ff
4`x-
3K)
Chapters +M&NsPaH _=H?uHUa
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
yzC)Q
Lt Adu 7]77
2[
4`x-
T6^

Please login or register for full access

Register

Already registered?  Login